KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Total Current Liabilities: 2010-2024

Historic Total Current Liabilities for Emergent BioSolutions (EBS) over the last 15 years, with Dec 2024 value amounting to $162.4 million.

  • Emergent BioSolutions' Total Current Liabilities fell 40.63% to $136.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $136.5 million, marking a year-over-year decrease of 40.63%. This contributed to the annual value of $162.4 million for FY2024, which is 75.07% down from last year.
  • Per Emergent BioSolutions' latest filing, its Total Current Liabilities stood at $162.4 million for FY2024, which was down 75.07% from $651.3 million recorded in FY2023.
  • In the past 5 years, Emergent BioSolutions' Total Current Liabilities ranged from a high of $1.2 billion in FY2022 and a low of $162.4 million during FY2024.
  • For the 3-year period, Emergent BioSolutions' Total Current Liabilities averaged around $680.9 million, with its median value being $651.3 million (2023).
  • Per our database at Business Quant, Emergent BioSolutions' Total Current Liabilities soared by 228.58% in 2022 and then crashed by 75.07% in 2024.
  • Emergent BioSolutions' Total Current Liabilities (Yearly) stood at $384.5 million in 2020, then dropped by 2.73% to $374.0 million in 2021, then surged by 228.58% to $1.2 billion in 2022, then plummeted by 47.00% to $651.3 million in 2023, then tumbled by 75.07% to $162.4 million in 2024.